1144P Chemo sensitivity score using an ex vivo 3D micro-tumor testing platform to predict clinical response to platinum-based therapy in patients with high-grade serous ovarian cancer

Annals of Oncology, vol. 36, pp. S710–S711

Authors 11

1. Judith R. Kroep Aachen Medical Oncology Department

   Leiden University Medical Center

   Affiliation as printed

   Medical Oncology Department, LUMC-Leiden University Medical Center, Leiden, Netherlands

2. Cor Doede de Kroon Aachen Gynaecology Department

   Leiden University Medical Center

   Affiliation as printed

   Gynaecology Department, LUMC-Leiden University Medical Center, Leiden, Netherlands

3. P.B. Ottevanger

   Radboud University Medical Center

   Affiliation as printed

   Medical Oncology Department, Radboud University Medical Center, Nijmegen, Nijmegen, Netherlands

4. Anne M. van Altena

   Radboud University Nijmegen · Radboud University Medical Center

   Affiliation as printed

   Gynaecologische Oncologie, Radboud University Medical Center, Nijmegen, Nijmegen, Netherlands

5. Timothy J. P. Sijsenaar
   Affiliation as printed

   Cancer Biology, VitroScan B.V, Leiden, Netherlands

6. Felix M. Behr
   Affiliation as printed

   Cancer Biology, VitroScan B.V, Leiden, Netherlands

7. Léa Le Large
   Affiliation as printed

   Bioinformatics, VitroScan B.V, Leiden, Netherlands

8. L. Ceton
   Affiliation as printed

   Bioinformatics, VitroScan B.V, Leiden, Netherlands

9. Diederick M. Keizer
   Affiliation as printed

   Clinical, VitroScan B.V, Leiden, Netherlands

10. Esmee Koedoot
    Affiliation as printed

    Cancer Biology, VitroScan B.V, Leiden, Netherlands

11. Willemijn Vader
    Affiliation as printed

    Management Dept., VitroScan B.V, Leiden, Netherlands